Trials / Not Yet Recruiting
Not Yet RecruitingNCT06413940
Exploring the Clinical Efficacy of Remote Management Applications Through Comprehensive Physical Therapy for Patients With Moderate to Severe Sleep Apnea
Effect of Mobile-health and Comprehensive Physical Therapy on Moderate-to-severe Obstructive Sleep Apnea Hypoventilation Syndrome
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 105 (estimated)
- Sponsor
- China National Center for Cardiovascular Diseases · Other Government
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
To observe comprehensive physical therapy program for OSAHS patients
Detailed description
This study proposes to conduct a randomized controlled trial ,using an APP and wearable devices to provide comprehensive physical therapy and monitoring for people with moderate to severe OSAHS,to assess the effectiveness and adherence of different physiotherapy programs for patients with moderate-to-severe OSAHS by observing the improvement of sleep apnea hypoventilation index (AHI), nocturnal minimum oxygen saturation (Low SpO2), mean oxygen saturation (Mean SpO2), and other health outcomes in the study population. It is expected to explore a clinical treatment pathway suitable for patients with moderate-to-severe OSAHS through mobile app and comprehensive physical therapy, improve the treatment adherence of OSAHS patients, enhance the level of health management services in hospitals, and obtain more physical health and health economic benefits.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Myofunctional Therapy | Oropharyngeal and tongue exercises : strengthening upper airway muscle 20 minutes |
| BEHAVIORAL | Inspiratory Muscle Training | Respiratory muscle strengthening:inspiratory muscle strengthening by resistive loading of 50% maximum inspiratory pressure. |
| BEHAVIORAL | Aerobic Exercise | Exercise intensity :40%-60% HRmax , 3-5 days/week |
Timeline
- Start date
- 2024-05-01
- Primary completion
- 2024-11-01
- Completion
- 2024-12-01
- First posted
- 2024-05-14
- Last updated
- 2024-05-14
Source: ClinicalTrials.gov record NCT06413940. Inclusion in this directory is not an endorsement.